1-7 of 7
Wanyan Ouyang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma

Available to Purchase
Clinical Trials & Observations
Mengmeng Pan, Di Wang, Jie Xu, Shiwei Jin, Yan Wang, Yi Tao, Yuanfang Liu, Wanyan Ouyang, Xiangqin Weng, Hongmei Yi, Yu Huang, Xinmei Cao, Shuhua Li, Fuyuan Zhang, Weiping Zhang, Chunrui Li, Jian-Qing Mi
Journal: Blood
Blood blood.2025030559.
https://doi.org/10.1182/blood.2025030559
Published: 2025
Includes: Supplemental data
Journal Articles

Flumatinib with Low-Intensity Chemotherapy in Elderly Patients with Newly Diagnosed BCR::ABL1-Positive Acute Lymphoblastic Leukemia

Free
Weiyang Liu, Yuanfang Liu, Yongmei Zhu, Xiangqin Weng, Cheng Wang, Wanyan Ouyang, Jie Xu, Weiping Zhang, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2024) 144 (Supplement 1): 5883.
https://doi.org/10.1182/blood-2024-210222
Published: 2024
Journal Articles

A Phase II Study of Flumatinib with Chemotherapy for Newly Diagnosed BCR::ABL1-Positive Acute Lymphoblastic Leukemia in Adults: Updated Results from RJ-ALL2020.2A Trial

Free
Weiyang Liu, Cheng Wang, Sijie Tang, Jiayi Ren, Lijun Peng, Yongmei Zhu, Xiangqin Weng, Wanyan Ouyang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5880.
https://doi.org/10.1182/blood-2023-180326
Published: 2023
Journal Articles

The Promising Third-Generation TKI Olverembatinib in Adult BCR::ABL1-Positive Acute Lymphoblastic Leukemia with T315I Mutation and Relapsed/Refractory Disease

Free
Weiyang Liu, Cheng Wang, Sijie Tang, Jiayi Ren, Lijun Peng, Yongmei Zhu, Xiangqin Weng, Wanyan Ouyang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5902.
https://doi.org/10.1182/blood-2023-188733
Published: 2023
Journal Articles

The First Report of Third-Generation TKI Olverembatinib in Adult Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia with T315I Mutation and Relapsed Disease

Free
Weiyang Liu, Yuanfang Liu, Yongmei Zhu, Xiangqin Weng, Cheng Wang, Wanyan Ouyang, Jie Xu, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2022) 140 (Supplement 1): 3266–3267.
https://doi.org/10.1182/blood-2022-166482
Published: 2022
Journal Articles

A Phase II Study of Flumatinib with Chemotherapy for Newly Diagnosed Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia in Adults：Preliminary Results from RJ-ALL2020.2A Trial

Free
Weiyang Liu, Yuanfang Liu, Yongmei Zhu, Xiangqin Weng, Cheng Wang, Wanyan Ouyang, Jie Xu, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 8981–8982.
https://doi.org/10.1182/blood-2022-165259
Published: 2022
Journal Articles

Mutations in the D1 Domain Inhibit Propeptide-Dependent Multimerization, Trafficking and Regulated Secretion of Von Willebrand Factor in VWD

Free
Jie Yin, Zhenni Ma, Jian Su, Xiaojuan Zhao, Zhaoyue Wang, Ziqiang Yu, Wanyan Ouyang, Xia Bai, Changgeng Ruan
Journal: Blood
Blood (2014) 124 (21): 1495.
https://doi.org/10.1182/blood.V124.21.1495.1495
Published: 2014